Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-07-11FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for fluoxetine from Aurobindo Pharma Limited, authorizing a new generic fluoxetine product under…
-
FDA approval · 2014-07-08FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
The FDA has approved a supplemental application for Celexa (citalopram) from Allergan, Inc.
-
FDA approval · 2014-07-08FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lexapro (escitalopram) submitted by Allergan, Inc.
-
FDA approval · 2014-07-02FDA Approved: NORPRAMIN — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for NORPRAMIN (desipramine hydrochloride) filed by Validus Pharmaceuticals LLC.
-
FDA approval · 2014-07-01FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc., confirming regulatory clearance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-07-01FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc., confirming approval of a generic tr…
-
FDA approval · 2014-06-30FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., marking an approval action un…
-
FDA approval · 2014-06-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2014-06-26FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for venlafaxine submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
FDA approval · 2014-06-25FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for trazodone hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2014-06-18FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2014-06-17FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for venlafaxine from BluePoint Laboratories under ANDA077653. This action authorizes a generic versi…
-
FDA approval · 2014-06-11FDA Approved: DULOXETINE DELAYED-RELEASE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved Breckenridge Pharmaceutical's original generic duloxetine hydrochloride delayed-release capsules, a generic version of the anti…
-
FDA approval · 2014-06-09FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for duloxetine hydrochloride, establishing a generic version of duloxetine.
-
FDA approval · 2014-06-02FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Citalopram from Hikma Pharmaceuticals USA Inc., confirming approval of a supplemental ANDA for t…
-
FDA approval · 2014-05-23FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)
FDA approves a supplemental application for FETZIMA (levomilnacipran hydrochloride) submitted by Allergan, Inc. This action updates regulato…
-
FDA approval · 2014-05-20FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for escitalopram oxalate by Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2014-04-22FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for quetiapine fumarate submitted by BluePoint Laboratories. This action grants updated regulatory a…
-
FDA approval · 2014-04-17FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
FDA notes a supplemental application for VIIBRYD (vilazodone hydrochloride) submitted by Allergan, Inc., related to the existing NDA for vil…
-
FDA approval · 2014-04-07FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) submitted by Allergan, Inc., updating the product's label…
-
FDA approval · 2014-03-28FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for GEODON (ziprasidone mesylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2014-03-18FDA Approved: MIRTAZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Mylan Pharmaceuticals' generic mirTAZAPine (mirtazapine).
-
FDA approval · 2014-02-07FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic Bupropion hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2014-01-10FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc., authorizing its manufacturing and…
-
FDA approval · 2014-01-08FDA Approved: DULOXETINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a duloxetine generic from Zydus Lifesciences Limited, enabling marketing for the same indications …